Overview
- 40 inspections across 40 sites are on record.
- 106 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2021-07-20.
At a glance
Inspections
40
Sites
40
Observations
106
Career since
Mar 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Smith & Nephew Wound Management | 20 Jul 2021 | Human Drugs | On file |
| Aparna Pharmaceuticals Private Limited | 15 Mar 2019 | Human Drugs | On file |
| Lupin Limited | 31 Aug 2018 | Human Drugs | On file |
| Avon Manufacturing (Guangzhou) Ltd. | 7 Jun 2018 | Human Drugs | On file |
| Jinan Jinda Pharmaceutical Chemistry Co., Ltd. | 18 May 2018 | Human Drugs | On file |
Sites inspected
Smith & Nephew Wound ManagementFort Worth, United States1 insp.
Aparna Pharmaceuticals Private LimitedSrikakulam, India1 insp.
Lupin LimitedTarapur, Thane, India1 insp.
Avon Manufacturing (Guangzhou) Ltd.Guangzhou, China1 insp.
Jinan Jinda Pharmaceutical Chemistry Co., Ltd.Zhangqui City (Jinan), China1 insp.
Co-investigators
Investigators who share inspections with this person.
Toyin B Oladimeji4 shared
Deborah J Parris4 shared
Nicole E Knowlton4 shared
Deyaa Shaheen3 shared
Liatte Krueger3 shared
Lane V Christensen2 shared
Concepcion Cruz2 shared
Jonathan W Chapman2 shared
Tenzin Jangchup1 shared
Dipesh K Shah1 shared
Full investigator report
Get the verbatim findings behind Eric L Dong's 106 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site